INS and Alzheimer disease: These observations collected in vitro and in animal models have been strengthened by clinical studies reporting that the failure in brain energy metabolism responsible for the cognitive decline during aging or AD could be driven by the development of brain insulin resistance particularly at the early stages [10,57].